Fiera Capital (Canada)’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.3M Buy
709,529
+23,473
+3% +$1.08M 0.14% 129
2025
Q4
$30.7M Buy
686,056
+166,057
+32% +$6.97M 0.1% 156
2025
Q3
$20.9M Sell
519,999
-10,684
-2% -$376K 0.07% 162
2025
Q2
$16.6M Buy
530,683
+1,241
+0.2% +$40.5K 0.06% 164
2025
Q1
$17.8M Sell
529,442
-6,445
-1% -$245K 0.06% 162
2024
Q4
$21M Sell
535,887
-18,313
-3% -$757K 0.07% 147
2024
Q3
$21.8M Sell
554,200
-28,679
-5% -$1.16M 0.07% 150
2024
Q2
$22.7M Buy
582,879
+6,337
+1% +$253K 0.07% 141
2024
Q1
$24.8M Buy
576,542
+23,512
+4% +$1.08M 0.07% 140
2023
Q4
$25.5M Sell
553,030
-7,516
-1% -$266K 0.08% 137
2023
Q3
$19.1M Buy
560,546
+11,205
+2% +$419K 0.06% 151
2023
Q2
$21.1M Buy
+549,341
New +$21.8M 0.06% 144

Other funds holding XENE